nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C19—Rosuvastatin—atherosclerosis	0.0646	0.089	CbGbCtD
Bicalutamide—CYP2C19—Simvastatin—atherosclerosis	0.0601	0.0827	CbGbCtD
Bicalutamide—CYP2C19—Lovastatin—atherosclerosis	0.0588	0.081	CbGbCtD
Bicalutamide—CYP2D6—Niacin—atherosclerosis	0.0578	0.0796	CbGbCtD
Bicalutamide—CYP2C9—Rosuvastatin—atherosclerosis	0.0537	0.074	CbGbCtD
Bicalutamide—CYP2C9—Simvastatin—atherosclerosis	0.05	0.0688	CbGbCtD
Bicalutamide—CYP2C9—Pravastatin—atherosclerosis	0.0489	0.0673	CbGbCtD
Bicalutamide—CYP2C9—Lovastatin—atherosclerosis	0.0489	0.0673	CbGbCtD
Bicalutamide—CYP2D6—Simvastatin—atherosclerosis	0.0457	0.0629	CbGbCtD
Bicalutamide—CYP2D6—Pravastatin—atherosclerosis	0.0447	0.0615	CbGbCtD
Bicalutamide—CYP2D6—Lovastatin—atherosclerosis	0.0447	0.0615	CbGbCtD
Bicalutamide—CYP3A4—Rosuvastatin—atherosclerosis	0.0312	0.043	CbGbCtD
Bicalutamide—CYP3A4—Ezetimibe—atherosclerosis	0.0312	0.043	CbGbCtD
Bicalutamide—CYP3A4—Simvastatin—atherosclerosis	0.029	0.04	CbGbCtD
Bicalutamide—CYP3A4—Pravastatin—atherosclerosis	0.0284	0.0391	CbGbCtD
Bicalutamide—CYP3A4—Lovastatin—atherosclerosis	0.0284	0.0391	CbGbCtD
Bicalutamide—Enzalutamide—ALB—atherosclerosis	0.0013	1	CrCbGaD
Bicalutamide—Sweating—Niacin—atherosclerosis	0.000617	0.00257	CcSEcCtD
Bicalutamide—Urinary tract infection—Pravastatin—atherosclerosis	0.000616	0.00256	CcSEcCtD
Bicalutamide—Chills—Lovastatin—atherosclerosis	0.000604	0.00251	CcSEcCtD
Bicalutamide—Cough—Rosuvastatin—atherosclerosis	0.000603	0.00251	CcSEcCtD
Bicalutamide—Angiopathy—Ezetimibe—atherosclerosis	0.000599	0.00249	CcSEcCtD
Bicalutamide—Immune system disorder—Ezetimibe—atherosclerosis	0.000596	0.00248	CcSEcCtD
Bicalutamide—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000595	0.00247	CcSEcCtD
Bicalutamide—Sinusitis—Pravastatin—atherosclerosis	0.000594	0.00247	CcSEcCtD
Bicalutamide—Alopecia—Lovastatin—atherosclerosis	0.000594	0.00247	CcSEcCtD
Bicalutamide—Myalgia—Rosuvastatin—atherosclerosis	0.000588	0.00245	CcSEcCtD
Bicalutamide—Alopecia—Ezetimibe—atherosclerosis	0.000583	0.00242	CcSEcCtD
Bicalutamide—Haemoglobin—Niacin—atherosclerosis	0.000581	0.00241	CcSEcCtD
Bicalutamide—Rhinitis—Niacin—atherosclerosis	0.000579	0.00241	CcSEcCtD
Bicalutamide—Mental disorder—Ezetimibe—atherosclerosis	0.000578	0.0024	CcSEcCtD
Bicalutamide—Haemorrhage—Niacin—atherosclerosis	0.000578	0.0024	CcSEcCtD
Bicalutamide—Flatulence—Lovastatin—atherosclerosis	0.000577	0.0024	CcSEcCtD
Bicalutamide—Malnutrition—Ezetimibe—atherosclerosis	0.000574	0.00239	CcSEcCtD
Bicalutamide—Rhinitis—Pravastatin—atherosclerosis	0.00057	0.00237	CcSEcCtD
Bicalutamide—Oedema peripheral—Niacin—atherosclerosis	0.000569	0.00237	CcSEcCtD
Bicalutamide—Confusional state—Rosuvastatin—atherosclerosis	0.000569	0.00236	CcSEcCtD
Bicalutamide—Back pain—Lovastatin—atherosclerosis	0.000566	0.00236	CcSEcCtD
Bicalutamide—Flatulence—Ezetimibe—atherosclerosis	0.000566	0.00235	CcSEcCtD
Bicalutamide—Pharyngitis—Pravastatin—atherosclerosis	0.000565	0.00235	CcSEcCtD
Bicalutamide—Chills—Simvastatin—atherosclerosis	0.000565	0.00235	CcSEcCtD
Bicalutamide—Muscle spasms—Lovastatin—atherosclerosis	0.000563	0.00234	CcSEcCtD
Bicalutamide—Infection—Rosuvastatin—atherosclerosis	0.00056	0.00233	CcSEcCtD
Bicalutamide—Visual impairment—Niacin—atherosclerosis	0.000557	0.00231	CcSEcCtD
Bicalutamide—Alopecia—Simvastatin—atherosclerosis	0.000556	0.00231	CcSEcCtD
Bicalutamide—Back pain—Ezetimibe—atherosclerosis	0.000556	0.00231	CcSEcCtD
Bicalutamide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000553	0.0023	CcSEcCtD
Bicalutamide—Muscle spasms—Ezetimibe—atherosclerosis	0.000552	0.0023	CcSEcCtD
Bicalutamide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000552	0.0023	CcSEcCtD
Bicalutamide—Mental disorder—Simvastatin—atherosclerosis	0.000551	0.00229	CcSEcCtD
Bicalutamide—Visual impairment—Pravastatin—atherosclerosis	0.000548	0.00228	CcSEcCtD
Bicalutamide—Flatulence—Simvastatin—atherosclerosis	0.00054	0.00224	CcSEcCtD
Bicalutamide—Angioedema—Lovastatin—atherosclerosis	0.000535	0.00222	CcSEcCtD
Bicalutamide—Anaemia—Ezetimibe—atherosclerosis	0.000531	0.00221	CcSEcCtD
Bicalutamide—Cardiac disorder—Pravastatin—atherosclerosis	0.000528	0.0022	CcSEcCtD
Bicalutamide—Muscle spasms—Simvastatin—atherosclerosis	0.000527	0.00219	CcSEcCtD
Bicalutamide—Angioedema—Ezetimibe—atherosclerosis	0.000525	0.00218	CcSEcCtD
Bicalutamide—Angiopathy—Niacin—atherosclerosis	0.000524	0.00218	CcSEcCtD
Bicalutamide—Chills—Niacin—atherosclerosis	0.000518	0.00216	CcSEcCtD
Bicalutamide—Arrhythmia—Niacin—atherosclerosis	0.000516	0.00215	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000514	0.00214	CcSEcCtD
Bicalutamide—Alopecia—Niacin—atherosclerosis	0.000511	0.00212	CcSEcCtD
Bicalutamide—Chills—Pravastatin—atherosclerosis	0.00051	0.00212	CcSEcCtD
Bicalutamide—Insomnia—Rosuvastatin—atherosclerosis	0.00051	0.00212	CcSEcCtD
Bicalutamide—Arrhythmia—Pravastatin—atherosclerosis	0.000508	0.00211	CcSEcCtD
Bicalutamide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000506	0.00211	CcSEcCtD
Bicalutamide—Anaemia—Simvastatin—atherosclerosis	0.000506	0.0021	CcSEcCtD
Bicalutamide—Malnutrition—Niacin—atherosclerosis	0.000503	0.00209	CcSEcCtD
Bicalutamide—Alopecia—Pravastatin—atherosclerosis	0.000503	0.00209	CcSEcCtD
Bicalutamide—Cough—Ezetimibe—atherosclerosis	0.000501	0.00208	CcSEcCtD
Bicalutamide—Angioedema—Simvastatin—atherosclerosis	0.0005	0.00208	CcSEcCtD
Bicalutamide—Myalgia—Lovastatin—atherosclerosis	0.000499	0.00207	CcSEcCtD
Bicalutamide—Chest pain—Lovastatin—atherosclerosis	0.000499	0.00207	CcSEcCtD
Bicalutamide—Anxiety—Lovastatin—atherosclerosis	0.000497	0.00207	CcSEcCtD
Bicalutamide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000496	0.00206	CcSEcCtD
Bicalutamide—Hypertension—Ezetimibe—atherosclerosis	0.000496	0.00206	CcSEcCtD
Bicalutamide—Flatulence—Niacin—atherosclerosis	0.000496	0.00206	CcSEcCtD
Bicalutamide—Tension—Niacin—atherosclerosis	0.000494	0.00205	CcSEcCtD
Bicalutamide—Chest pain—Ezetimibe—atherosclerosis	0.000489	0.00203	CcSEcCtD
Bicalutamide—Myalgia—Ezetimibe—atherosclerosis	0.000489	0.00203	CcSEcCtD
Bicalutamide—Nervousness—Niacin—atherosclerosis	0.000488	0.00203	CcSEcCtD
Bicalutamide—Flatulence—Pravastatin—atherosclerosis	0.000488	0.00203	CcSEcCtD
Bicalutamide—Dry mouth—Lovastatin—atherosclerosis	0.000488	0.00203	CcSEcCtD
Bicalutamide—Tension—Pravastatin—atherosclerosis	0.000486	0.00202	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000486	0.00202	CcSEcCtD
Bicalutamide—Muscle spasms—Niacin—atherosclerosis	0.000484	0.00201	CcSEcCtD
Bicalutamide—Constipation—Rosuvastatin—atherosclerosis	0.000482	0.00201	CcSEcCtD
Bicalutamide—Pain—Rosuvastatin—atherosclerosis	0.000482	0.00201	CcSEcCtD
Bicalutamide—Confusional state—Lovastatin—atherosclerosis	0.000482	0.002	CcSEcCtD
Bicalutamide—Nervousness—Pravastatin—atherosclerosis	0.000481	0.002	CcSEcCtD
Bicalutamide—Dry mouth—Ezetimibe—atherosclerosis	0.000478	0.00199	CcSEcCtD
Bicalutamide—Muscle spasms—Pravastatin—atherosclerosis	0.000476	0.00198	CcSEcCtD
Bicalutamide—Infection—Lovastatin—atherosclerosis	0.000475	0.00197	CcSEcCtD
Bicalutamide—Confusional state—Ezetimibe—atherosclerosis	0.000473	0.00197	CcSEcCtD
Bicalutamide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000468	0.00195	CcSEcCtD
Bicalutamide—Myalgia—Simvastatin—atherosclerosis	0.000466	0.00194	CcSEcCtD
Bicalutamide—Chest pain—Simvastatin—atherosclerosis	0.000466	0.00194	CcSEcCtD
Bicalutamide—Infection—Ezetimibe—atherosclerosis	0.000466	0.00194	CcSEcCtD
Bicalutamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000465	0.00193	CcSEcCtD
Bicalutamide—Anxiety—Simvastatin—atherosclerosis	0.000465	0.00193	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000461	0.00192	CcSEcCtD
Bicalutamide—Nervous system disorder—Ezetimibe—atherosclerosis	0.00046	0.00191	CcSEcCtD
Bicalutamide—Angioedema—Niacin—atherosclerosis	0.00046	0.00191	CcSEcCtD
Bicalutamide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000459	0.00191	CcSEcCtD
Bicalutamide—Anaemia—Pravastatin—atherosclerosis	0.000458	0.0019	CcSEcCtD
Bicalutamide—Anorexia—Lovastatin—atherosclerosis	0.000456	0.00189	CcSEcCtD
Bicalutamide—Skin disorder—Ezetimibe—atherosclerosis	0.000455	0.00189	CcSEcCtD
Bicalutamide—Angioedema—Pravastatin—atherosclerosis	0.000452	0.00188	CcSEcCtD
Bicalutamide—Syncope—Niacin—atherosclerosis	0.000451	0.00188	CcSEcCtD
Bicalutamide—Confusional state—Simvastatin—atherosclerosis	0.000451	0.00187	CcSEcCtD
Bicalutamide—Urticaria—Rosuvastatin—atherosclerosis	0.000448	0.00186	CcSEcCtD
Bicalutamide—Oedema—Simvastatin—atherosclerosis	0.000447	0.00186	CcSEcCtD
Bicalutamide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000446	0.00185	CcSEcCtD
Bicalutamide—Infection—Simvastatin—atherosclerosis	0.000444	0.00185	CcSEcCtD
Bicalutamide—Loss of consciousness—Niacin—atherosclerosis	0.000442	0.00184	CcSEcCtD
Bicalutamide—Cough—Niacin—atherosclerosis	0.000439	0.00182	CcSEcCtD
Bicalutamide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000438	0.00182	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000435	0.00181	CcSEcCtD
Bicalutamide—Insomnia—Lovastatin—atherosclerosis	0.000432	0.0018	CcSEcCtD
Bicalutamide—Cough—Pravastatin—atherosclerosis	0.000432	0.0018	CcSEcCtD
Bicalutamide—Paraesthesia—Lovastatin—atherosclerosis	0.000429	0.00178	CcSEcCtD
Bicalutamide—Myalgia—Niacin—atherosclerosis	0.000428	0.00178	CcSEcCtD
Bicalutamide—Hypertension—Pravastatin—atherosclerosis	0.000428	0.00178	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000427	0.00178	CcSEcCtD
Bicalutamide—Anorexia—Simvastatin—atherosclerosis	0.000426	0.00177	CcSEcCtD
Bicalutamide—Dyspnoea—Lovastatin—atherosclerosis	0.000426	0.00177	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000425	0.00177	CcSEcCtD
Bicalutamide—Insomnia—Ezetimibe—atherosclerosis	0.000424	0.00176	CcSEcCtD
Bicalutamide—Myalgia—Pravastatin—atherosclerosis	0.000422	0.00175	CcSEcCtD
Bicalutamide—Chest pain—Pravastatin—atherosclerosis	0.000422	0.00175	CcSEcCtD
Bicalutamide—Paraesthesia—Ezetimibe—atherosclerosis	0.000421	0.00175	CcSEcCtD
Bicalutamide—Dyspepsia—Lovastatin—atherosclerosis	0.000421	0.00175	CcSEcCtD
Bicalutamide—Anxiety—Pravastatin—atherosclerosis	0.00042	0.00175	CcSEcCtD
Bicalutamide—Dry mouth—Niacin—atherosclerosis	0.000419	0.00174	CcSEcCtD
Bicalutamide—Dyspnoea—Ezetimibe—atherosclerosis	0.000418	0.00174	CcSEcCtD
Bicalutamide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000415	0.00173	CcSEcCtD
Bicalutamide—Decreased appetite—Lovastatin—atherosclerosis	0.000415	0.00173	CcSEcCtD
Bicalutamide—Dyspepsia—Ezetimibe—atherosclerosis	0.000413	0.00172	CcSEcCtD
Bicalutamide—Fatigue—Lovastatin—atherosclerosis	0.000412	0.00171	CcSEcCtD
Bicalutamide—Oedema—Niacin—atherosclerosis	0.00041	0.00171	CcSEcCtD
Bicalutamide—Constipation—Lovastatin—atherosclerosis	0.000409	0.0017	CcSEcCtD
Bicalutamide—Pain—Lovastatin—atherosclerosis	0.000409	0.0017	CcSEcCtD
Bicalutamide—Confusional state—Pravastatin—atherosclerosis	0.000407	0.00169	CcSEcCtD
Bicalutamide—Decreased appetite—Ezetimibe—atherosclerosis	0.000407	0.00169	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000407	0.00169	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000405	0.00168	CcSEcCtD
Bicalutamide—Asthenia—Rosuvastatin—atherosclerosis	0.000405	0.00168	CcSEcCtD
Bicalutamide—Insomnia—Simvastatin—atherosclerosis	0.000404	0.00168	CcSEcCtD
Bicalutamide—Oedema—Pravastatin—atherosclerosis	0.000404	0.00168	CcSEcCtD
Bicalutamide—Fatigue—Ezetimibe—atherosclerosis	0.000404	0.00168	CcSEcCtD
Bicalutamide—Shock—Niacin—atherosclerosis	0.000404	0.00168	CcSEcCtD
Bicalutamide—Infection—Pravastatin—atherosclerosis	0.000401	0.00167	CcSEcCtD
Bicalutamide—Paraesthesia—Simvastatin—atherosclerosis	0.000401	0.00167	CcSEcCtD
Bicalutamide—Pain—Ezetimibe—atherosclerosis	0.000401	0.00167	CcSEcCtD
Bicalutamide—Constipation—Ezetimibe—atherosclerosis	0.000401	0.00167	CcSEcCtD
Bicalutamide—Pruritus—Rosuvastatin—atherosclerosis	0.000399	0.00166	CcSEcCtD
Bicalutamide—Skin disorder—Niacin—atherosclerosis	0.000399	0.00166	CcSEcCtD
Bicalutamide—Dyspnoea—Simvastatin—atherosclerosis	0.000399	0.00166	CcSEcCtD
Bicalutamide—Hyperhidrosis—Niacin—atherosclerosis	0.000397	0.00165	CcSEcCtD
Bicalutamide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000396	0.00165	CcSEcCtD
Bicalutamide—Feeling abnormal—Lovastatin—atherosclerosis	0.000394	0.00164	CcSEcCtD
Bicalutamide—Dyspepsia—Simvastatin—atherosclerosis	0.000393	0.00164	CcSEcCtD
Bicalutamide—Anorexia—Niacin—atherosclerosis	0.000391	0.00163	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000391	0.00162	CcSEcCtD
Bicalutamide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000391	0.00162	CcSEcCtD
Bicalutamide—Decreased appetite—Simvastatin—atherosclerosis	0.000389	0.00162	CcSEcCtD
Bicalutamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000386	0.00161	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000386	0.0016	CcSEcCtD
Bicalutamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000386	0.0016	CcSEcCtD
Bicalutamide—Fatigue—Simvastatin—atherosclerosis	0.000385	0.0016	CcSEcCtD
Bicalutamide—Anorexia—Pravastatin—atherosclerosis	0.000385	0.0016	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000383	0.00159	CcSEcCtD
Bicalutamide—Constipation—Simvastatin—atherosclerosis	0.000382	0.00159	CcSEcCtD
Bicalutamide—Pain—Simvastatin—atherosclerosis	0.000382	0.00159	CcSEcCtD
Bicalutamide—Urticaria—Lovastatin—atherosclerosis	0.00038	0.00158	CcSEcCtD
Bicalutamide—Abdominal pain—Lovastatin—atherosclerosis	0.000378	0.00157	CcSEcCtD
Bicalutamide—Body temperature increased—Lovastatin—atherosclerosis	0.000378	0.00157	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000374	0.00155	CcSEcCtD
Bicalutamide—Dizziness—Rosuvastatin—atherosclerosis	0.000373	0.00155	CcSEcCtD
Bicalutamide—Urticaria—Ezetimibe—atherosclerosis	0.000372	0.00155	CcSEcCtD
Bicalutamide—Insomnia—Niacin—atherosclerosis	0.000371	0.00154	CcSEcCtD
Bicalutamide—Abdominal pain—Ezetimibe—atherosclerosis	0.000371	0.00154	CcSEcCtD
Bicalutamide—Body temperature increased—Ezetimibe—atherosclerosis	0.000371	0.00154	CcSEcCtD
Bicalutamide—Paraesthesia—Niacin—atherosclerosis	0.000369	0.00153	CcSEcCtD
Bicalutamide—Feeling abnormal—Simvastatin—atherosclerosis	0.000368	0.00153	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000368	0.00153	CcSEcCtD
Bicalutamide—Dyspnoea—Niacin—atherosclerosis	0.000366	0.00152	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000366	0.00152	CcSEcCtD
Bicalutamide—Insomnia—Pravastatin—atherosclerosis	0.000366	0.00152	CcSEcCtD
Bicalutamide—Somnolence—Niacin—atherosclerosis	0.000365	0.00152	CcSEcCtD
Bicalutamide—Paraesthesia—Pravastatin—atherosclerosis	0.000363	0.00151	CcSEcCtD
Bicalutamide—Dyspepsia—Niacin—atherosclerosis	0.000361	0.0015	CcSEcCtD
Bicalutamide—Dyspnoea—Pravastatin—atherosclerosis	0.00036	0.0015	CcSEcCtD
Bicalutamide—Decreased appetite—Niacin—atherosclerosis	0.000357	0.00148	CcSEcCtD
Bicalutamide—Dyspepsia—Pravastatin—atherosclerosis	0.000356	0.00148	CcSEcCtD
Bicalutamide—Rash—Rosuvastatin—atherosclerosis	0.000356	0.00148	CcSEcCtD
Bicalutamide—Dermatitis—Rosuvastatin—atherosclerosis	0.000355	0.00148	CcSEcCtD
Bicalutamide—Urticaria—Simvastatin—atherosclerosis	0.000355	0.00148	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000354	0.00147	CcSEcCtD
Bicalutamide—Body temperature increased—Simvastatin—atherosclerosis	0.000353	0.00147	CcSEcCtD
Bicalutamide—Abdominal pain—Simvastatin—atherosclerosis	0.000353	0.00147	CcSEcCtD
Bicalutamide—Headache—Rosuvastatin—atherosclerosis	0.000353	0.00147	CcSEcCtD
Bicalutamide—Hypersensitivity—Lovastatin—atherosclerosis	0.000352	0.00146	CcSEcCtD
Bicalutamide—Decreased appetite—Pravastatin—atherosclerosis	0.000351	0.00146	CcSEcCtD
Bicalutamide—Pain—Niacin—atherosclerosis	0.000351	0.00146	CcSEcCtD
Bicalutamide—Fatigue—Pravastatin—atherosclerosis	0.000348	0.00145	CcSEcCtD
Bicalutamide—Pain—Pravastatin—atherosclerosis	0.000346	0.00144	CcSEcCtD
Bicalutamide—Constipation—Pravastatin—atherosclerosis	0.000346	0.00144	CcSEcCtD
Bicalutamide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000345	0.00144	CcSEcCtD
Bicalutamide—Asthenia—Lovastatin—atherosclerosis	0.000343	0.00143	CcSEcCtD
Bicalutamide—Pruritus—Lovastatin—atherosclerosis	0.000338	0.00141	CcSEcCtD
Bicalutamide—Asthenia—Ezetimibe—atherosclerosis	0.000336	0.0014	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Niacin—atherosclerosis	0.000336	0.0014	CcSEcCtD
Bicalutamide—Nausea—Rosuvastatin—atherosclerosis	0.000335	0.00139	CcSEcCtD
Bicalutamide—Feeling abnormal—Pravastatin—atherosclerosis	0.000333	0.00138	CcSEcCtD
Bicalutamide—Pruritus—Ezetimibe—atherosclerosis	0.000332	0.00138	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00033	0.00137	CcSEcCtD
Bicalutamide—Hypersensitivity—Simvastatin—atherosclerosis	0.000329	0.00137	CcSEcCtD
Bicalutamide—Diarrhoea—Lovastatin—atherosclerosis	0.000327	0.00136	CcSEcCtD
Bicalutamide—Urticaria—Niacin—atherosclerosis	0.000326	0.00136	CcSEcCtD
Bicalutamide—Abdominal pain—Niacin—atherosclerosis	0.000324	0.00135	CcSEcCtD
Bicalutamide—Body temperature increased—Niacin—atherosclerosis	0.000324	0.00135	CcSEcCtD
Bicalutamide—Urticaria—Pravastatin—atherosclerosis	0.000321	0.00133	CcSEcCtD
Bicalutamide—Asthenia—Simvastatin—atherosclerosis	0.000321	0.00133	CcSEcCtD
Bicalutamide—Diarrhoea—Ezetimibe—atherosclerosis	0.000321	0.00133	CcSEcCtD
Bicalutamide—Abdominal pain—Pravastatin—atherosclerosis	0.000319	0.00133	CcSEcCtD
Bicalutamide—Body temperature increased—Pravastatin—atherosclerosis	0.000319	0.00133	CcSEcCtD
Bicalutamide—Pruritus—Simvastatin—atherosclerosis	0.000316	0.00131	CcSEcCtD
Bicalutamide—Dizziness—Lovastatin—atherosclerosis	0.000316	0.00131	CcSEcCtD
Bicalutamide—Dizziness—Ezetimibe—atherosclerosis	0.00031	0.00129	CcSEcCtD
Bicalutamide—Diarrhoea—Simvastatin—atherosclerosis	0.000306	0.00127	CcSEcCtD
Bicalutamide—Vomiting—Lovastatin—atherosclerosis	0.000304	0.00126	CcSEcCtD
Bicalutamide—Hypersensitivity—Niacin—atherosclerosis	0.000302	0.00126	CcSEcCtD
Bicalutamide—Rash—Lovastatin—atherosclerosis	0.000301	0.00125	CcSEcCtD
Bicalutamide—Dermatitis—Lovastatin—atherosclerosis	0.000301	0.00125	CcSEcCtD
Bicalutamide—Headache—Lovastatin—atherosclerosis	0.000299	0.00124	CcSEcCtD
Bicalutamide—Vomiting—Ezetimibe—atherosclerosis	0.000298	0.00124	CcSEcCtD
Bicalutamide—Hypersensitivity—Pravastatin—atherosclerosis	0.000298	0.00124	CcSEcCtD
Bicalutamide—Dizziness—Simvastatin—atherosclerosis	0.000296	0.00123	CcSEcCtD
Bicalutamide—Rash—Ezetimibe—atherosclerosis	0.000296	0.00123	CcSEcCtD
Bicalutamide—Dermatitis—Ezetimibe—atherosclerosis	0.000295	0.00123	CcSEcCtD
Bicalutamide—Asthenia—Niacin—atherosclerosis	0.000294	0.00122	CcSEcCtD
Bicalutamide—Headache—Ezetimibe—atherosclerosis	0.000294	0.00122	CcSEcCtD
Bicalutamide—Pruritus—Niacin—atherosclerosis	0.00029	0.00121	CcSEcCtD
Bicalutamide—Asthenia—Pravastatin—atherosclerosis	0.00029	0.00121	CcSEcCtD
Bicalutamide—Pruritus—Pravastatin—atherosclerosis	0.000286	0.00119	CcSEcCtD
Bicalutamide—Vomiting—Simvastatin—atherosclerosis	0.000284	0.00118	CcSEcCtD
Bicalutamide—Nausea—Lovastatin—atherosclerosis	0.000284	0.00118	CcSEcCtD
Bicalutamide—Rash—Simvastatin—atherosclerosis	0.000282	0.00117	CcSEcCtD
Bicalutamide—Dermatitis—Simvastatin—atherosclerosis	0.000282	0.00117	CcSEcCtD
Bicalutamide—Diarrhoea—Niacin—atherosclerosis	0.000281	0.00117	CcSEcCtD
Bicalutamide—Headache—Simvastatin—atherosclerosis	0.00028	0.00116	CcSEcCtD
Bicalutamide—Nausea—Ezetimibe—atherosclerosis	0.000278	0.00116	CcSEcCtD
Bicalutamide—Diarrhoea—Pravastatin—atherosclerosis	0.000277	0.00115	CcSEcCtD
Bicalutamide—Dizziness—Niacin—atherosclerosis	0.000271	0.00113	CcSEcCtD
Bicalutamide—Dizziness—Pravastatin—atherosclerosis	0.000267	0.00111	CcSEcCtD
Bicalutamide—Nausea—Simvastatin—atherosclerosis	0.000266	0.0011	CcSEcCtD
Bicalutamide—Vomiting—Niacin—atherosclerosis	0.000261	0.00109	CcSEcCtD
Bicalutamide—Rash—Niacin—atherosclerosis	0.000259	0.00108	CcSEcCtD
Bicalutamide—Dermatitis—Niacin—atherosclerosis	0.000259	0.00108	CcSEcCtD
Bicalutamide—Headache—Niacin—atherosclerosis	0.000257	0.00107	CcSEcCtD
Bicalutamide—Vomiting—Pravastatin—atherosclerosis	0.000257	0.00107	CcSEcCtD
Bicalutamide—Rash—Pravastatin—atherosclerosis	0.000255	0.00106	CcSEcCtD
Bicalutamide—Dermatitis—Pravastatin—atherosclerosis	0.000255	0.00106	CcSEcCtD
Bicalutamide—Headache—Pravastatin—atherosclerosis	0.000253	0.00105	CcSEcCtD
Bicalutamide—Nausea—Niacin—atherosclerosis	0.000244	0.00101	CcSEcCtD
Bicalutamide—Nausea—Pravastatin—atherosclerosis	0.00024	0.000998	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.48e-05	0.00109	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.48e-05	0.00109	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.44e-05	0.00108	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PARP1—atherosclerosis	3.37e-05	0.00106	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.36e-05	0.00105	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LDLRAP1—atherosclerosis	3.32e-05	0.00104	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3.32e-05	0.00104	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—SERPINE1—atherosclerosis	3.31e-05	0.00104	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.24e-05	0.00102	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—ESR2—atherosclerosis	3.19e-05	0.001	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	3.18e-05	0.000998	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLTP—atherosclerosis	3.12e-05	0.000979	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.06e-05	0.000961	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	3.05e-05	0.000958	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	3.03e-05	0.00095	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.96e-05	0.000928	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.92e-05	0.000917	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.89e-05	0.000907	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.87e-05	0.000902	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLTP—atherosclerosis	2.87e-05	0.000901	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.86e-05	0.000896	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLTP—atherosclerosis	2.85e-05	0.000893	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.82e-05	0.000883	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.79e-05	0.000875	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.78e-05	0.000871	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LTA4H—atherosclerosis	2.71e-05	0.000849	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCG8—atherosclerosis	2.71e-05	0.000849	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.67e-05	0.000838	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.64e-05	0.000827	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.62e-05	0.000822	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.6e-05	0.000817	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SIRT1—atherosclerosis	2.57e-05	0.000807	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.54e-05	0.000798	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.52e-05	0.000792	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LTA4H—atherosclerosis	2.49e-05	0.000781	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCG8—atherosclerosis	2.49e-05	0.000781	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCG8—atherosclerosis	2.47e-05	0.000774	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LTA4H—atherosclerosis	2.47e-05	0.000774	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.44e-05	0.000764	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.3e-05	0.000722	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.25e-05	0.000706	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCG1—atherosclerosis	2.14e-05	0.000671	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PPARA—atherosclerosis	2.14e-05	0.000671	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.05e-05	0.000643	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—FABP4—atherosclerosis	2.01e-05	0.000631	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LCAT—atherosclerosis	2.01e-05	0.000631	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2e-05	0.000626	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOA4—atherosclerosis	1.97e-05	0.000619	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCG1—atherosclerosis	1.97e-05	0.000617	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.95e-05	0.000612	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP7A1—atherosclerosis	1.94e-05	0.000608	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—ESR1—atherosclerosis	1.94e-05	0.000608	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLTP—atherosclerosis	1.88e-05	0.000589	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—FABP4—atherosclerosis	1.85e-05	0.00058	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LCAT—atherosclerosis	1.85e-05	0.00058	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.85e-05	0.00058	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—FABP4—atherosclerosis	1.83e-05	0.000575	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LCAT—atherosclerosis	1.83e-05	0.000575	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOA4—atherosclerosis	1.82e-05	0.00057	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOA4—atherosclerosis	1.8e-05	0.000565	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP27A1—atherosclerosis	1.79e-05	0.000562	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.78e-05	0.00056	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.77e-05	0.000555	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PPARG—atherosclerosis	1.77e-05	0.000554	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.76e-05	0.000554	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.72e-05	0.00054	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	1.7e-05	0.000533	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOA2—atherosclerosis	1.7e-05	0.000533	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	1.7e-05	0.000533	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALOX15—atherosclerosis	1.7e-05	0.000533	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.69e-05	0.000529	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCG5—atherosclerosis	1.68e-05	0.000527	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.68e-05	0.000526	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.65e-05	0.000517	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.63e-05	0.000513	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.63e-05	0.000511	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.63e-05	0.000511	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LPA—atherosclerosis	1.62e-05	0.000509	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.61e-05	0.000505	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SERPINE1—atherosclerosis	1.59e-05	0.0005	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—BGN—atherosclerosis	1.57e-05	0.000493	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.57e-05	0.000493	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.56e-05	0.00049	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.56e-05	0.00049	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOA2—atherosclerosis	1.56e-05	0.00049	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.56e-05	0.00049	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.56e-05	0.000489	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOA5—atherosclerosis	1.55e-05	0.000488	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOA2—atherosclerosis	1.55e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.55e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.55e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.55e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.54e-05	0.000484	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.53e-05	0.00048	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.53e-05	0.00048	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.51e-05	0.000474	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.5e-05	0.000469	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LPA—atherosclerosis	1.49e-05	0.000468	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.48e-05	0.000464	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LPA—atherosclerosis	1.48e-05	0.000464	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.47e-05	0.00046	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.46e-05	0.000459	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.44e-05	0.000453	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—BGN—atherosclerosis	1.44e-05	0.000453	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—BGN—atherosclerosis	1.43e-05	0.000449	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOA5—atherosclerosis	1.43e-05	0.000449	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.42e-05	0.000446	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOA5—atherosclerosis	1.42e-05	0.000445	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.38e-05	0.000432	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.38e-05	0.000432	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.36e-05	0.000428	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.35e-05	0.000423	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.34e-05	0.000419	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.34e-05	0.000419	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.33e-05	0.000418	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.33e-05	0.000417	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.32e-05	0.000413	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.3e-05	0.000407	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.29e-05	0.000404	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LIPC—atherosclerosis	1.29e-05	0.000404	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.29e-05	0.000404	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOC3—atherosclerosis	1.28e-05	0.000402	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LDLR—atherosclerosis	1.27e-05	0.000399	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CETP—atherosclerosis	1.24e-05	0.00039	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.22e-05	0.000382	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—FABP4—atherosclerosis	1.21e-05	0.000379	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LCAT—atherosclerosis	1.21e-05	0.000379	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.19e-05	0.000374	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.19e-05	0.000373	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOA4—atherosclerosis	1.19e-05	0.000372	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LIPC—atherosclerosis	1.18e-05	0.000372	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.18e-05	0.000371	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOC3—atherosclerosis	1.18e-05	0.000369	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.17e-05	0.000369	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LIPC—atherosclerosis	1.17e-05	0.000368	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LDLR—atherosclerosis	1.17e-05	0.000367	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOC3—atherosclerosis	1.17e-05	0.000366	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.17e-05	0.000366	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LDLR—atherosclerosis	1.16e-05	0.000364	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.16e-05	0.000364	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CETP—atherosclerosis	1.14e-05	0.000359	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CETP—atherosclerosis	1.13e-05	0.000355	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.12e-05	0.000353	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.09e-05	0.000343	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.08e-05	0.00034	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.08e-05	0.000338	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.06e-05	0.000331	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MAPK3—atherosclerosis	1.04e-05	0.000325	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.03e-05	0.000324	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.02e-05	0.000321	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.02e-05	0.000321	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.02e-05	0.000321	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.02e-05	0.000321	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOA2—atherosclerosis	1.02e-05	0.000321	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.01e-05	0.000318	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.01e-05	0.000317	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCA1—atherosclerosis	1e-05	0.000314	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LPA—atherosclerosis	9.75e-06	0.000306	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—BGN—atherosclerosis	9.44e-06	0.000296	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOA5—atherosclerosis	9.35e-06	0.000293	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.24e-06	0.00029	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCA1—atherosclerosis	9.21e-06	0.000289	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCA1—atherosclerosis	9.13e-06	0.000287	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9e-06	0.000282	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.69e-06	0.000273	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMOX1—atherosclerosis	8.59e-06	0.00027	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOB—atherosclerosis	8.23e-06	0.000258	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM1—atherosclerosis	8.01e-06	0.000251	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.9e-06	0.000248	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LPL—atherosclerosis	7.86e-06	0.000247	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.84e-06	0.000246	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.79e-06	0.000245	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LIPC—atherosclerosis	7.74e-06	0.000243	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOC3—atherosclerosis	7.7e-06	0.000241	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GPX1—atherosclerosis	7.67e-06	0.000241	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LDLR—atherosclerosis	7.65e-06	0.00024	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOB—atherosclerosis	7.57e-06	0.000238	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOB—atherosclerosis	7.51e-06	0.000235	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CETP—atherosclerosis	7.47e-06	0.000234	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CD36—atherosclerosis	7.47e-06	0.000234	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.36e-06	0.000231	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM1—atherosclerosis	7.3e-06	0.000229	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LPL—atherosclerosis	7.23e-06	0.000227	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LPL—atherosclerosis	7.17e-06	0.000225	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.16e-06	0.000225	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTHFR—atherosclerosis	7.08e-06	0.000222	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GPX1—atherosclerosis	7.05e-06	0.000221	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GPX1—atherosclerosis	6.99e-06	0.000219	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—atherosclerosis	6.99e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARA—atherosclerosis	6.94e-06	0.000218	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CD36—atherosclerosis	6.87e-06	0.000216	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CD36—atherosclerosis	6.81e-06	0.000214	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.76e-06	0.000212	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AGT—atherosclerosis	6.72e-06	0.000211	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOE—atherosclerosis	6.59e-06	0.000207	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CAV1—atherosclerosis	6.53e-06	0.000205	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOA1—atherosclerosis	6.51e-06	0.000204	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.51e-06	0.000204	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.45e-06	0.000202	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARA—atherosclerosis	6.39e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARA—atherosclerosis	6.33e-06	0.000199	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AGT—atherosclerosis	6.18e-06	0.000194	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AGT—atherosclerosis	6.13e-06	0.000192	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOE—atherosclerosis	6.06e-06	0.00019	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.02e-06	0.000189	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOE—atherosclerosis	6.01e-06	0.000188	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CAV1—atherosclerosis	6e-06	0.000188	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOA1—atherosclerosis	5.99e-06	0.000188	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CAV1—atherosclerosis	5.95e-06	0.000187	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.95e-06	0.000187	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOA1—atherosclerosis	5.94e-06	0.000186	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARG—atherosclerosis	5.74e-06	0.00018	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—INS—atherosclerosis	5.63e-06	0.000177	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.47e-06	0.000172	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.42e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARG—atherosclerosis	5.28e-06	0.000166	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARG—atherosclerosis	5.23e-06	0.000164	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—INS—atherosclerosis	5.18e-06	0.000162	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.17e-06	0.000162	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALB—atherosclerosis	5.16e-06	0.000162	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—INS—atherosclerosis	5.13e-06	0.000161	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOB—atherosclerosis	4.95e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NOS3—atherosclerosis	4.94e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.81e-06	0.000151	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALB—atherosclerosis	4.75e-06	0.000149	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LPL—atherosclerosis	4.73e-06	0.000148	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALB—atherosclerosis	4.7e-06	0.000148	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPX1—atherosclerosis	4.61e-06	0.000145	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NOS3—atherosclerosis	4.54e-06	0.000142	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.51e-06	0.000142	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NOS3—atherosclerosis	4.5e-06	0.000141	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CD36—atherosclerosis	4.49e-06	0.000141	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.26e-06	0.000134	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARA—atherosclerosis	4.17e-06	0.000131	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.15e-06	0.00013	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.12e-06	0.000129	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AGT—atherosclerosis	4.04e-06	0.000127	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOE—atherosclerosis	3.96e-06	0.000124	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CAV1—atherosclerosis	3.93e-06	0.000123	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOA1—atherosclerosis	3.92e-06	0.000123	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.58e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARG—atherosclerosis	3.45e-06	0.000108	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—INS—atherosclerosis	3.38e-06	0.000106	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALB—atherosclerosis	3.1e-06	9.74e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NOS3—atherosclerosis	2.97e-06	9.31e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.71e-06	8.52e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—atherosclerosis	2.27e-06	7.12e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—atherosclerosis	2.09e-06	6.55e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—atherosclerosis	2.07e-06	6.49e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—atherosclerosis	1.36e-06	4.28e-05	CbGpPWpGaD
